KEFAMAST Dry Cow Intramammary Suspension

Land: Írland

Tungumál: enska

Heimild: HPRA (Health Products Regulatory Authority)

Kauptu það núna

Download Vara einkenni (SPC)
12-06-2017

Virkt innihaldsefni:

Cefalexin; Dihydrostreptomycin

Fáanlegur frá:

Bimeda Chemicals

ATC númer:

QJ51RD01

INN (Alþjóðlegt nafn):

Cefalexin; Dihydrostreptomycin

Skammtar:

500/500 mg/syringe

Lyfjaform:

Intramammary suspension

Gerð lyfseðils:

POM: Prescription Only Medicine as defined in relevant national legislation

Meðferðarhópur:

Cattle

Lækningarsvæði:

cefalexin, combinations with other antibacterials

Ábendingar:

Antibacterial

Leyfisstaða:

Authorised

Leyfisdagur:

1988-10-01

Vara einkenni

                                SUMMARY OF PRODUCT CHARACTERISTICS
1 NAME OF THE VETERINARY MEDICINAL PRODUCT
KEFAMAST Dry Cow Intramammary Suspension
2 QUALITATIVE AND QUANTITATIVE COMPOSITION
For a full list of excipients see section 6.1.
3 PHARMACEUTICAL FORM
Intramammary suspension.
10 ml intramammary syringe containing 9 g of a smooth pale pink or
pale yellow sterile product.
4 CLINICAL PARTICULARS
4.1 TARGET SPECIES
Dry Cows.
4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
For the treatment of sub clinical mastitis infection present at drying
off and to assist in preventing new infections occurring
during the dry period.
4.3 CONTRAINDICATIONS
Do not use in animals with known hypersensitivity to the active
ingredients.
Do not use in lactating cows.
Do not use within 40 days of the estimated calving date.
4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES
None.
Each syringe contains:
ACTIVE SUBSTANCES
Cefalexin
500 mg
Dihydrostreptomycin
(as Dihydrostreptomycin Sulphate) 500 mg
H
E
A
L
T
H
P
R
O
D
U
C
T
S
R
E
G
U
L
A
T
O
R
Y
A
U
T
H
O
R
I
T
Y
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
_D_
_a_
_t_
_e_
_ _
_P_
_r_
_i_
_n_
_t_
_e_
_d_
_ _
_0_
_8_
_/_
_0_
_8_
_/_
_2_
_0_
_1_
_6_
_C_
_R_
_N_
_ _
_7_
_0_
_2_
_3_
_7_
_5_
_2_
_p_
_a_
_g_
_e_
_ _
_n_
_u_
_m_
_b_
_e_
_r_
_:_
_ _
_1_
4.5 SPECIAL PRECAUTIONS FOR USE
SPECIAL PRECAUTION(S) FOR USE IN ANIMALS
Not intended for use within 40 days of the estimated calving date.
SPECIAL PRECAUTIONS TO BE TAKEN BY THE PERSON ADMINISTERING THE
VETERINARY MEDICINAL PRODUCT TO ANIMALS
Operators should avoid contact with this preparation as occasional
skin allergy may occur.
Penicillins and c
                                
                                Lestu allt skjalið